Quest Diagnostics vs Natera stock
Side by side in plain words: who keeps more of its sales, grows faster, costs less and owes less.
Quest Diagnostics is more profitable and is cheaper for its profits. Natera grows faster and has less debt.
Side by side
| Quest Diagnostics | Natera | |
|---|---|---|
| $28.6 billion | $46.3 billion | |
| 9.0% | -9.0% | |
| +3.2% | +42.6% | |
| 28.8× | No profit yet | |
| 3.3 years | Net cash | |
| 8.1% | -11.1% | |
| 1.7% | – |
How we compare
Four contests with the same rules as each stock page: profit kept from sales (higher wins), yearly sales growth across the last reports, up to five years (higher wins), price per unit of yearly profit (lower P/E wins; a company without profit loses) and debt in years of earnings (lower wins). A winner is only named when both companies have the number.
More comparisons: Quest Diagnostics vs Labcorp Holdings · Natera vs Labcorp Holdings · Natera vs Eli Lilly